Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 2, 2000, Pages 339-344

  Hascoët, Martine ^a   Bourin, Michel ^a   Colombel, Marie Claude ^a   Fiocco, Alexandra J ^a   Baker, Glen B ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Acute administration; Antidepressants; Anxiolytic like activity; Four plate test; Mice; SSRIs; Tricyclics

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; MAPROTILINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME INHIBITION; FREEZING; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; TRAINING; TRANQUILIZING ACTIVITY;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; AVOIDANCE LEARNING; MALE; MICE; PUNISHMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 0033952432     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00191-4     Document Type: Article

References (28)

1. Ardid D., Marty H., Fialip J., Privat A.M., Eschalier A., Lavarenne J. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam. Clin. Pharmacol. 6:1992;75-82.
2. Aron C., Simon P., Larousse C., Boissier J.R. Evaluation of a rapid technique detecting minor tranquillizers. Neuropharmacology. 10:1971;459-469.
3. Bartoskyk G.D., Schoenherr U. Differential effects of competitive benzodiazepine receptor antagonists on the anti-conflict activity of Gö 4962. Behav. Neural Biol. 48:1987;317-319.
4. Boissier J.R., Simon P., Aron C. A new method for rapid screening of minor tranquillizers in mice. Eur. J. Pharmacol. 4:1968;145-151.
5. Borsini F., Brambilla A., Cesana R., Doneti A. The effect of DAU 6215, a novel 5-HT3 antagonist, in animal models of anxiety. Pharmacol. Res. 27:1993;151-164.
6. Bourin M., Baker G.B. The future of antidepressants. Biomed. Pharmacother. 50:1996;7-12.
7. Bourin M., Hascoët M., Mansouri B., Colombel M.C., Bradwejn J. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J. Psychiatr. Neurosci. 17:1992;72-77.
8. Bourin M., Redrobe J.P., Hascoet M., Colombel M.C., Baker G.B. A schematic representation of the psychopharmacological profile of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20:1996;1389-1902.
9. Chopin P., Briley M. Animal models of anxiety. The effects of compounds that modify 5-HT neurotransmission Trends Pharmacol. Sci. 8:1987;383-389.
10. B receptor antagonist CI-988 and diazepam in the four plates test. Psychopharmacology (Berlin). 112:1993;452-454.
11. Duteil G.M., Rambert F.A., Pessonnier J., Gombert R., Assous E. A possible alpha adrenergic mechanisms for drug (CRL 40028) induced hyperactivity. Eur. J. Pharmacol. 59:1979;121-123.
12. Fasmer O.B., Hunskaar S., Hole K. Antinociceptive effects of serotonergic reuptake inhibitors in mice. Neuropharmacology. 28:1989;1363-1366.
13. File S. Animal models for predicting clinical efficacy of anxiolytic drugs. Social behaviour Neuropsychobiology. 13:1985;55-62.
14. Griebel G. Variability in the effect of 5-HT related compounds in experimental models of anxiety. Evidence for multiple mechanism of 5-HT in anxiety or never-ending story? Pol. J. Pharmacol. 48:1996;129-136.
15. Handley S.L., McBlane J.W. Opposite effects of fluoxetine in two animal models of anxiety. Br. J. Pharmacol. (Suppl.). 107:1992;466P.
16. Hascoët M., Bourin M., Bradwejn J. Behavioral models in mice. Implication of the alpha noradrenergic system. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;825-840.
17. Hashimoto S., Inoue T., Koyama T. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berlin). 123:1996;182-186.
18. Hyttel J. Pharmacological characterisation of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 9:1996;19-26.
19. Insel T.R., Mueller E.A., Alterman I., Linnoila M., Murphy D.L. Obsessive-compulsive disorder and serotonin. Is there a connection? Biol. Psychiatry. 20:1985;1174-1188.
20. Iversen S.D. 5HT and anxiety. Neuropharmacology. 23:1984;1553-1560.
21. Jones G.H., Schneider C., Schneider H.H., Seidler J., Cole B.J., Stephens D.N. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in mouse. An analysis on fractional receptor occupancies Psychopharmacology (Berlin). 114:1994;191-199.
22. Kahn R.J., McNair D.M., Lipman R.S., Covi L., Rikels K., Downing R., Fisher S., Frankenthaler L.M. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II Efficacy in anxious outpatients. Arch. Gen. Psychiatry. 43:1986;79-85.
23. Linnoila M., Eckhardt M., Durcan M., Lister R., Martin P. Interactions of serotonin with ethanol. Clinical and animal studies Psychopharmacol. Bull. 23:1987;452-457.
24. Redrobe J.P., Bourin M., Colombel M.C., Baker B.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berlin). 138:1998;1-8.
25. Redrobe J.P., Bourin M., Colombel M.C., Baker G.B. Psychopharmacological profile of the selective reuptake inhibitor, paroxetine. Implication of the noradrenergic and serotoninergic mechanisms J. Psychopharmacol. 12:1998;379-386.
26. Rocca P., Fonzo V., Scotta M., Zanalda E., Ravizza L. Paroxetine efficacy in the treatment of generalised anxiety disorder. Acta Psychiatr. Scand. 95:1997;444-450.
27. Stephens D.N., Kehr W. β-Carbolines can enhance or antagonise the effects of punishment in mice. Psychopharmacology (Berlin). 18:1985;143-147.
28. Stephens D.N., Meldrum B.S., Weidmann R., Schneider C., Grützner M. Does the excitatory acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology (Berlin). 90:1986;166-169.